biosimilar Eptacog alfa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for biosimilar Eptacog alfa, covering 2021-02-04 to 2021-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors [Phase 3]